Dmitry Balyasny’s Cytosorbents Corp CTSO Stock Holding History

Dmitry Balyasny’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-11,761	Closed	-$26K	–	2908
2022 Q2	$26K	Buy	+11,761	New	+$27K	﹤0.01%	2447

Other funds holding CTSO

Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Dmitry Balyasny's CTSO Position: Q3 2022 in Review

Dmitry Balyasny sold out of Cytosorbents Corp (CTSO) in Q3 2022, closing a stake of 11,761 shares — an estimated $26K sold.

Dmitry Balyasny first reported a position in CTSO in Q2 2022 and held it in 1 quarter. The position peaked at $26K in Q2 2022. 60 funds tracked by Wall St. Rank hold CTSO as of Q3 2022.

Dmitry Balyasny reported no remaining Cytosorbents Corp position as of Q3 2022 after selling out during the quarter.
Dmitry Balyasny sold 11,761 Cytosorbents Corp shares in Q3 2022, an estimated $26K.
Dmitry Balyasny first reported a position in Cytosorbents Corp in Q2 2022 and held it in 1 quarter.
Dmitry Balyasny's Cytosorbents Corp position peaked at $26K in Q2 2022.
60 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2022.

Based on Balyasny Asset Management's 13F filing for Q3 2022, filed 15 Nov 2022.